Search
for
Sort by
Research 481–510 of 1000+
- What can the hair tell us about COVID‐19?
- Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase
- Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiative
- Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial.
- Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors
- Direct-to-consumer telemedicine in primary care settings: A scoping review of contemporary empirical literature
- Prevalence and predictors of persistent post-COVID-19 symptoms
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- Long-term COVID-19 complications: a multidisciplinary clinic follow-up approach
- SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
- Fármacos de uso frecuente en dermatología como terapia para COVID-19
- Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan
- Brazilian pulmonology guidelines on Delphi panel for post-coronavirus disease 2019
- Clinical diagnosis of COVID-19: a prompt, feasible, and sensitive diagnostic tool for COVID-19 based on a 1,757-patient cohort (The AndroCoV Clinical Scoring for COVID-19 diagnosis)
- A scoping review of alopecia areata and its relationship to COVID-19 vaccinations
- The effect of low-level laser therapy on severe acute respiratory syndrome coronavirus-2 infected cells
- The Association between COVID-19 Infection and Gabrin Sign: A Case-Control Study
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- Testosterone in COVID-19: An Adversary Bane or Comrade Boon
- The immune response to COVID‐19: Does sex matter?
- May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
- Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations
- Contributions of dermatologists to COVID ‐19 research: A brief systematic review
- Sequelae of long COVID, known and unknown: A review of updated information
- Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19